Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Syndax Pharmaceuticals (SNDX) Inventory (2016 - 2025)

Historic Inventory for Syndax Pharmaceuticals (SNDX) over the last 9 years, with Q3 2025 value amounting to $25.0 million.

  • Syndax Pharmaceuticals' Inventory changed N/A to $25.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $25.0 million, marking a year-over-year change of. This contributed to the annual value of $366000.0 for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, Syndax Pharmaceuticals' Inventory is $25.0 million.
  • In the past 5 years, Syndax Pharmaceuticals' Inventory registered a high of $25.0 million during Q3 2025, and its lowest value of $22000.0 during Q2 2021.
  • Its 3-year average for Inventory is $8.0 million, with a median of $2.5 million in 2024.
  • Within the past 5 years, the most significant YoY rise in Syndax Pharmaceuticals' Inventory was 6184.21% (2021), while the steepest drop was 8503.4% (2021).
  • Over the past 3 years, Syndax Pharmaceuticals' Inventory (Quarter) stood at $22000.0 in 2021, then skyrocketed by 1563.64% to $366000.0 in 2024, then surged by 6730.6% to $25.0 million in 2025.
  • Its Inventory was $25.0 million in Q3 2025, compared to $17.7 million in Q2 2025 and $4.7 million in Q1 2025.